Are these calls for papers currently accepting submissions?

Records are included only when the publisher source exposes a deadline on or after the database date. Authors should still verify the publisher page before submitting.

Do the pages replace journal submission guidelines?

No. The pages help researchers discover CFPs and generate research ideas, but submission rules, scope, fees, and reference style must be checked on the official publisher page.

DrAIStudio

Pharmacology, Toxicology and Pharmaceutics calls for papers accepting submissions

Current open calls for papers in Pharmacology, Toxicology and Pharmaceutics, with deadlines, publisher links, and Journal Finder ranking signals where matched.

Open Pharmacology, Toxicology and Pharmaceutics CFPs

Migrastatic Agents, Metastasis, and Mitochondrial Metabolism: Emerging Strategies for Cancer Drug Discovery

Deadline 2027-02-28FrontiersIndexed (Active)

Pharmacology, Toxicology and Pharmaceutics calls for papers accepting submissions

Open Pharmacology, Toxicology and Pharmaceutics CFPs

Migrastatic Agents, Metastasis, and Mitochondrial Metabolism: Emerging Strategies for Cancer Drug Discovery

Migrastatic Agents, Metastasis, and Mitochondrial Metabolism: Emerging Strategies for Cancer Drug Discovery

Bioactive Natural Products from Marine and Terrestrial Sources: Isolation, Structural Diversity, and Biological Activity

Bioactive Natural Products from Marine and Terrestrial Sources: Isolation, Structural Diversity, and Biological Activity

Aquaculture as an Antibiotic Resistance Hotspot: Environmental Dissemination, One Health Impacts, and Novel Mitigation Strategies

Aquaculture as an Antibiotic Resistance Hotspot: Environmental Dissemination, One Health Impacts, and Novel Mitigation Strategies

Molecular basis of chemosensitivity

Molecular basis of chemosensitivity

Steroid Derivatives as Emerging Drug Candidates

Steroid Derivatives as Emerging Drug Candidates

Advances in Personalized Management of Patients with Airways Diseases

Advances in Personalized Management of Patients with Airways Diseases

Smart Materials and Devices for Stimuli-Responsive Drug Delivery

Smart Materials and Devices for Stimuli-Responsive Drug Delivery

Antimicrobial and Antiparasitic Drug Discovery: Experimental Pharmacology, Computational and AI/ML Approaches, and Translational Strategies

Computational Pharmacogenomics: Artificial Intelligence and Machine Learning for Variant Effect Prediction and Clinical Translation

Computational Pharmacogenomics: Artificial Intelligence and Machine Learning for Variant Effect Prediction and Clinical Translation

Fragment-Based Drug Discovery: Innovations, Challenges, and Translational Opportunities in Experimental Pharmacology

Fragment-Based Drug Discovery: Innovations, Challenges, and Translational Opportunities in Experimental Pharmacology

Institutional Implementation of Pharmacogenomics: Health Systems Policies, Barriers, and Best Practice Models

Institutional Implementation of Pharmacogenomics: Health Systems Policies, Barriers, and Best Practice Models

Pharmacogenomic Variability in Drug Metabolism: From Nuclear Receptors to Clinical Enzyme Regulation

Pharmacogenomic Variability in Drug Metabolism: From Nuclear Receptors to Clinical Enzyme Regulation

Protein Structure, Dynamics, and Function in Modern Drug Discovery

Protein Structure, Dynamics, and Function in Modern Drug Discovery

Real-World Safety Outcomes and Policy Responses to Adverse Drug Reactions

Real-World Safety Outcomes and Policy Responses to Adverse Drug Reactions

Artificial Intelligence in Drug Metabolism and Transport: From Multi-Omics Insights to Clinical and Pharmacological Validation

Artificial Intelligence in Drug Metabolism and Transport: From Multi-Omics Insights to Clinical and Pharmacological Validation

Nanoformulation Strategies to Overcome Multi-Drug Resistance in Cancer: From Pharmacological Characterization to Preclinical Translation

Nanoformulation Strategies to Overcome Multi-Drug Resistance in Cancer: From Pharmacological Characterization to Preclinical Translation

Volume II: Integrated PK/PD and Drug Metabolism Approaches in Drug Development and Evaluation

Shifting perspectives: In vitro, in vivo, transgenic and disease models in inhalation toxicology

Immunogenic Cell Death: From Mechanistic Insights to Pharmacological Intervention and Drug Discovery

Immunogenic Cell Death: From Mechanistic Insights to Pharmacological Intervention and Drug Discovery

Emerging Applications and Approaches Using Fish Cell Lines

Emerging Applications and Approaches Using Fish Cell Lines

Molecular Mechanisms in Biology: Integrating Computational Modeling, Artificial Intelligence, and Experimental Approaches

Molecular Mechanisms in Biology: Integrating Computational Modeling, Artificial Intelligence, and Experimental Approaches

Adaptive Liver-Targeted Drug Delivery in Hepatic Disease and Impairment

Adaptive Liver-Targeted Drug Delivery in Hepatic Disease and Impairment

Emerging Horizons of Metformin: Exploring Recent Advances and Addressing Challenges in Research and Clinical Utilization, Volume II

Emerging Horizons of Metformin: Exploring Recent Advances and Addressing Challenges in Research and Clinical Utilization, Volume II

Advances in Biophysical Hit Validation in Drug Discovery

Advances in Biophysical Hit Validation in Drug Discovery

Targeting Metabolic Reprogramming in Cancer: From Multi-Omics Signatures to Functional Pharmacology

Targeting Metabolic Reprogramming in Cancer: From Multi-Omics Signatures to Functional Pharmacology

Anatomically Targeted Antifungal Drug Delivery and Combination Therapies

Anatomically Targeted Antifungal Drug Delivery and Combination Therapies

Bioinspired and Biomimetic Drug Delivery Strategies to Overcome Resistance in Solid Tumors

Bioinspired and Biomimetic Drug Delivery Strategies to Overcome Resistance in Solid Tumors

Computational Modeling in Toxicology: NAMs-based Artificial Intelligence, Mechanistic in Silico Approaches, and Software Platforms

Computational Modeling in Toxicology: NAMs-based Artificial Intelligence, Mechanistic in Silico Approaches, and Software Platforms

Early warning and prioritization of contaminants of emerging concern for risk assessment

Early warning and prioritization of contaminants of emerging concern for risk assessment

Physicochemical and In Silico ADME Profiling of Gut Microbiota-Derived Metabolites: Bridging Computational Prediction and Experimental Validation

Physicochemical and In Silico ADME Profiling of Gut Microbiota-Derived Metabolites: Bridging Computational Prediction and Experimental Validation

Mixtures and combined exposures in environmental toxicology

Mixtures and combined exposures in environmental toxicology

Real-World Economic Evaluation of Advanced Therapy Medicinal Products After Market Access

Real-World Economic Evaluation of Advanced Therapy Medicinal Products After Market Access

Quantum Chemistry-Guided Design of Nitrogen-Containing Heterocycles as Anticancer Agents: From Reactivity Descriptors to Biological Validation

Quantum Chemistry-Guided Design of Nitrogen-Containing Heterocycles as Anticancer Agents: From Reactivity Descriptors to Biological Validation

Advanced Drug Delivery for Special Patient Populations: From Physiological Barriers to Model-Informed Clinical Translation

Advanced Drug Delivery for Special Patient Populations: From Physiological Barriers to Model-Informed Clinical Translation

Drug Metabolism, Pharmacokinetics, and Bioanalytical Strategies for Small Molecules and Oligonucleotide Therapeutics

Drug Metabolism, Pharmacokinetics, and Bioanalytical Strategies for Small Molecules and Oligonucleotide Therapeutics

Innovative Wastewater-Based Epidemiology: Revolutionizing Infectious Disease Monitoring

Innovative Wastewater-Based Epidemiology: Revolutionizing Infectious Disease Monitoring

Engineering Extracellular Communication: Glycan Interfaces, Extracellular Vesicles and Soluble Mediators for Integrative and Regenerative Pharmacology

Engineering Extracellular Communication: Glycan Interfaces, Extracellular Vesicles and Soluble Mediators for Integrative and Regenerative Pharmacology

Integrating Artificial Intelligence, Multi-Omics, and Nanomedicine to Target the Disease Immune Microenvironment

Integrating Artificial Intelligence, Multi-Omics, and Nanomedicine to Target the Disease Immune Microenvironment

Targeting Anion Channels and Associated Epithelial Ion Channels in Health and Disease: TMEM16/Anoctamins, ENaC, VRAC, and Beyond

Structure-Dependent Toxicological Profiles of PFAS: Mechanistic Determinants, Predictive Models, and Organ-Specific Biomarkers

Structure-Dependent Toxicological Profiles of PFAS: Mechanistic Determinants, Predictive Models, and Organ-Specific Biomarkers

Targeting Neuroinflammation in Spinal Cord Injury: From Inflammatory Mechanisms to Pharmacological Interventions

Targeting Neuroinflammation in Spinal Cord Injury: From Inflammatory Mechanisms to Pharmacological Interventions